MexXY-OprM efflux pump is required for antagonism of aminoglycosides by divalent cations in Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 7, 2001, Pages 2001-2007

  Mao, W ^a   Warren, M S ^a   Lee, A ^a   Mistry, A ^a   Lomovskaya, O ^a  

^a Microcide Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; APRAMYCIN; GENTAMICIN; HABEKACIN; NETILMICIN; STREPTOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; DRUG UPTAKE; GRAM NEGATIVE INFECTION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BIOLOGICAL TRANSPORT; CALCIUM; CARRIER PROTEINS; CATIONS, DIVALENT; DIPEPTIDES; DRUG INTERACTIONS; DRUG RESISTANCE, MICROBIAL; HUMANS; MAGNESIUM; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA;

EID: 0034950853     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.7.2001-2007.2001     Document Type: Article

References (41)

1. The role of the outer membrane of Pseudomonas aeruginosa in the uptake of aminoglycoside antibiotics
2. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides
3. Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: A model for entry of streptomycin and gentamicin in susceptible and resistant bacteria
4. Streptomycin accumulation in susceptible and resistant strains of Escherichia coli and Pseudomonas aeruginosa
5. Relation of aerobiosis and ionic strength to the uptake of dihydrostreptomycin in Escherichia coli
6. Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetracycline, gentamicin, polymyxin B, and carbenicillin
7. Gentamicin-lipopolysaccharide interactions in Pseudomonas aeruginosa
8. Interplay between the efflux pump and the outer membrane permeability barrier in fluorescent dye accumulation in Pseudomonas aeruginosa
9. Antibiotic uptake in gram-negative bacteria
10. Involvement of the outer membrane in gentamicin and streptomycin uptake and killing in Pseudomonas aeruginosa
11. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria
12. A novel transducing phage. Its role in recognition of a possible new host-controlled modification system in Pseudomonas aeruginosa
13. Metal ion-tetracycline interactions in biological fluids. Part 8. Potentiometric and spectroscopic studies on the formation of Ca(II) and Mg(II) complexes with 4-dedimethylamino-tetracycline and 6-desoxy-6-demethyl-tetracycline
14. Effect of magnesium complexation by fluoroquinolones on their antibacterial properties
15. Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance
16. Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa
17. Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa
18. Identification and characterization of efflux pump inhibitors in Pseudomonas aeruginosa
19. Interplay between chromosomal beta-lactamase and the MexAB-OprM efflux system in intrinsic resistance to beta-lactams in Pseudomonas aeruginosa
20. Contribution of the MexXY-OprM efflux system to intrinsic resistance in Pseudomonas aeruginosa
21. Effect of salt concentration on the apparent in vitro susceptibility of Pseudomonas and other gram-negative bacilli to gentamicin
22. The most frequent aminoglycoside resistance mechanisms - Changes with time and geographic area: A reflection of aminoglycoside usage patterns?
23. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei
24. Resistance to beta-lactam antibiotics in Pseudomonas aeruginosa due to interplay between the MexAB-OprM efflux pump and beta-lactamase
25. Antibiotic resistance caused by gram-negative multidrug efflux pumps
26. Multidrug efflux pumps of gram-negative bacteria
27. Multiple antibiotic resistance and efflux
28. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump
29. Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria
30. Cloning and sequence analysis of an EnvCD homologue in Pseudomonas aeruginosa: Regulation by iron and possible involvement in the secretion of the siderophore pyoverdine
31. Multiple antibiotic resistance in Pseudomonas aeruginosa: Evidence for involvement of an efflux operon
32. Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression
33. Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin
34. AcrD of Escherichia coli is an aminoglycoside efflux pump
35. Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability
36. Multidrug resistance mechanisms: Drug efflux across two membranes
37. AcrA is a highly asymmetric protein capable of spanning the periplasm
38. Bypassing the periplasm: Reconstitution of the AcrAB multidrug efflux pump of Escherichia coli
39. Contribution of outer membrane efflux protein OprM to antibiotic resistance in Pseudomonas aeruginosa independent of MexAB
40. Activity of aminoglycoside antibiotics against Pseudomonas aeruginosa: Specificity and site of calcium and magnesium antagonism